RecruitingNCT05388461

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy for Severe or Treatment Resistant Depression - Predictors of Response, Side Effects, and Relapse

Sponsor

Haukeland University Hospital

Enrollment

600 participants

Start Date

Mar 13, 2013

Study Type

OBSERVATIONAL

Conditions

Depressive Disorder

Summary

The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013,
written consent to enrolment into the Regional Register for neurostimulation.

Exclusion Criteria2

ECT performed on other indications than major depression.
No consent to the register.

Interventions

OTHERelectroconvulsive therapy

electroconvulsive therapy

Locations(2)

Haukeland University Hospital

Bergen, Norway

Stavanger University Hospital

Stavanger, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05388461

Related Trials

Intervention Effect of Temporal Interference Stimulation (TIS) on Depressive Disorder

NCT071913922 locations